Jeffrey W. Albers
CIK 1638474 · CEO AND PRESIDENT · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.21M
Companies
5
Total Filings
93
Lifetime Open-Market Net
-$64.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRE | Director | 27,360 | $80.79 | $2.21M | -$257.2K | 6 | 2026-05-29 |
| KYMR | Director | 0 | $86.20 | $0 | -$1.80M | 12 | 2025-12-08 |
| Blueprint Medicines Corp (BPMC) Delisted | Director | 0 | $129.46 | $0 | -$62.43M | 69 | 2025-07-21 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 1 | 2023-11-27 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Director | 4,152 | $11.19 | $46.5K | $0 | 5 | 2022-06-30 |
Recent Filings · Page 8 of 10
93 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-19 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$485.9K | EDGAR |
| 2019-06-14 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$1.66M | EDGAR |
| 2019-06-11 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-19 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$1.69M | EDGAR |
| 2019-03-05 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-21 | Blueprint Medicines Corp (BPMC) Delisted | Exer (M) | +28,961 | $54.2K | EDGAR |
| 2018-11-07 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$1.23M | EDGAR |
| 2018-08-08 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$1.37M | EDGAR |
| 2018-06-27 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Conv (C) | +4,152 | $0 | EDGAR |
| 2018-05-09 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$1.54M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.